Covid19
Showing NaN - NaN of 32
SARS-CoV Infection, Covid19 Trial in Mexico, Puerto Rico, United States (SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination
Active, not recruiting
- SARS-CoV Infection
- Covid19
- SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period)
- +5 more
-
Birmingham, Alabama
- +155 more
Dec 16, 2022
Covid19 Trial in Brazil, United States (Remdesivir, Remdesivir Placebo, Aviptadil)
Completed
- Covid19
- Remdesivir
- +4 more
-
Tucson, Arizona
- +39 more
Dec 16, 2022
Covid19 Trial in United States (sotrovimab)
Recruiting
- Covid19
- sotrovimab
-
Riverside, California
- +9 more
Nov 2, 2022
COVID-19 Respiratory Outcomes Registry
Active, not recruiting
- Covid19
- Questionnaires and Patient Reported Outcomes (PROs)
- +10 more
-
Saint Louis, Missouri
- +3 more
Oct 11, 2022
Covid19, Cytokine Release Syndrome Trial in Netherlands, Switzerland, United States (dapansutrile capsules, capsules)
Recruiting
- Covid19
- Cytokine Release Syndrome
- dapansutrile capsules
- placebo capsules
-
Denver, Colorado
- +13 more
Sep 16, 2022
Covid19, ME/CFS, SARS COV2 Trial in United States
Active, not recruiting
- Covid19
- +5 more
-
Los Angeles, California
- +7 more
Sep 1, 2022
Covid19 Trial in United States (Apixaban 2.5 MG, Placebo)
Active, not recruiting
- Covid19
- Apixaban 2.5 MG
- Placebo
-
Phoenix, Arizona
- +120 more
Jul 1, 2022
Covid19 Trial in San Diego, Hialeah, Houston (TQ Formula/Tab)
Completed
- Covid19
- TQ Formula/Tab
-
San Diego, California
- +2 more
Mar 23, 2022
COVID19, ARDS Trial in United States (CK0802, Placebo)
Completed
- COVID19
- ARDS
- CK0802
- Placebo
-
Baltimore, Maryland
- +4 more
Mar 8, 2022
Covid19 Trial in Worldwide (Sotrovimab (Gen1), Sotrovimab (Gen2))
Active, not recruiting
- Covid19
- Sotrovimab (Gen1)
- Sotrovimab (Gen2)
-
Anniston, Alabama
- +30 more
Feb 4, 2022